Zelira Therapeutics Meets Primary Endpoints for Phase (1b/2a) Medicinal Cannabis Trial for Insomnia

Zelira Therapeutics Meets Primary Endpoints for Phase (1b/2a) Medicinal Cannabis Trial for Insomnia CLICK HERE to Read This Article At The Original Source

PERTH, Australia, Feb. 18, 2020 /PRNewswire/ — Teleconference 11am (AEDT) today with Osagie Imasogie, Zelira Chairman and Dr Richard Hopkins, Managing Director-ex USA Toll free dial‐in (Australia): 1800 908 299 Conference ID: 10004335 (more dial in options p4) Zelira Therapeutics Ltd…

Author: HEDGE

Hedge Accordingly was founded ahead of the global financial crisis in January of 2008, with the goal of providing our readers our unique take on latest news on stocks, wall street, volatility, news on wall street, articles on investing, trading, options, stocks, futures, #cnbc, #crudeoil, Bitcoin. Hedge Accordingly produces both original, and aggregated Wallst news content from top publishers around the world. We curate aggregated content covering the latest news on politics, stocks, wall street, and the tech industry. We also provide free stock charting, quotes and a bitcoin, forex and currency exchange. Learn More About HEDGEaccordingly.com